Cardiovascular disease in inflammatory rheumatic diseases

被引：121
作者：
Castaneda, Santos [1 ]
Nurmohamed, Michael T. [2 ]
Gonzalez-Gay, Miguel A. [3 ]
机构：
[1] Univ Autonoma Madrid, Div Rheumatol, Hosp Princesa, IIS IP, C Diego Leon 62, Madrid 28006, Spain
[2] Vrije Univ Amsterdam Med Ctr, Amsterdam Rheumatol & Immunol Ctr, Reade POB 7057, NL-1007 MB Amsterdam, Netherlands
[3] Univ Cantabria, Epidemiol Genet & Atherosclerosis Res Grp System, Hosp Univ Marques de Valdecilla, IDIVAL,Rheumatol Div, Avda Valdecilla S-N, Santander 39008, Spain
来源：
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY | 2016年 / 30卷 / 05期
关键词：
Cardiovascular disease; Cardiovascular risk factors; Cardiovascular risk assessment; Rheumatoid arthritis; Spondyloarthritis; Ankylosing spondylitis; Psoriatic arthritis; PSORIATIC-ARTHRITIS PATIENTS; CORONARY-HEART-DISEASE; C-REACTIVE PROTEIN; HIGH-DENSITY-LIPOPROTEIN; INTIMA-MEDIA THICKNESS; SERUM URIC-ACID; RISK-FACTORS; SUBCLINICAL ATHEROSCLEROSIS; ANKYLOSING-SPONDYLITIS; MYOCARDIAL-INFARCTION;
D O I：
10.1016/j.berh.2016.10.006
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Chronic inflammatory rheumatic diseases (IRD), including rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis, are prevalent conditions worldwide, with a considerable burden on healthcare systems. They are associated with increased cardiovascular (CV) morbidity and mortality. In this review, we focused on the epidemiology, traditional CV risk factors, genetics, and the link between chronic inflammation, atherosclerosis, and CV disease. Remarkably, patients with IRD have higher vulnerability to atheromatous plaques. The risk of unstable plaques is higher in patients with rheumatoid arthritis than in controls. Active disease is a characteristic ascribed to vulnerability and rupture of plaques and a cause of thrombosis in IRD. Management of CV risk in patients with IRD includes optimal control of disease activity. CV risk stratification by applying risk charts is also essential. Imaging techniques might be useful to determine the actual CV risk of patients with IRD who are included in the category of intermediate or moderate CV risk. (C) 2016 Elsevier Ltd. All rights reserved.
引用
收藏
页码：851 / 869
页数：19
相关论文
共 151 条
[141]   Improvement of Lipid Profile Is Accompanied by Atheroprotective Alterations in High-Density Lipoprotein Composition Upon Tumor Necrosis Factor Blockade A Prospective Cohort Study in Ankylosing Spondylitis [J].
van Eijk, I. C. ;
de Vries, M. K. ;
Levels, J. H. M. ;
Peters, M. J. L. ;
Huizer, E. E. ;
Dijkmans, B. A. C. ;
van der Horst-Bruinsma, I. E. ;
Hazenberg, B. P. C. ;
van de Stadt, R. J. ;
Wolbink, G. J. ;
Nurmohamed, M. T. .
ARTHRITIS AND RHEUMATISM, 2009, 60 (05) :1324-1330
[142]   Increased disease activity is associated with a deteriorated lipid profile in patients with ankylosing spondylitis [J].
van Halm, V. P. ;
van Denderen, J. C. ;
Peters, M. J. L. ;
Twisk, J. W. R. ;
van der Paardt, M. ;
van der Horst-Bruinsma, I. E. ;
van de Stadt, R. J. ;
de Koning, M. H. M. T. ;
Dijkmans, B. A. C. ;
Nurmohamed, M. T. .
ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 (11) :1473-1477
[143]   Rheumatoid arthritis versus diabetes as a risk factor for cardiovascular disease: a cross-sectional study, the CARRE Investigation [J].
van Halm, V. P. ;
Peters, M. J. L. ;
Voskuyl, A. E. ;
Boers, M. ;
Lems, W. F. ;
Visser, M. ;
Stehouwer, C. D. A. ;
Spijkerman, A. M. W. ;
Dekker, J. M. ;
Nijpels, G. ;
Heine, R. J. ;
Bouter, L. M. ;
Smulders, Y. M. ;
Dijkmans, B. A. C. ;
Nurmohamed, M. T. .
ANNALS OF THE RHEUMATIC DISEASES, 2009, 68 (09) :1395-1400
[144]   The Effect of TNF-alpha Blocking Therapy on Lipid Levels in Rheumatoid Arthritis: A Meta-Analysis [J].
van Sijl, Alper M. ;
Peters, Mike J. L. ;
Knol, Dirk L. ;
de Vet, Riekie H. C. ;
Sattar, Naveed ;
Dijkmans, Ben A. C. ;
Smulders, Yvo M. ;
Nurmohamed, Michael T. .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 2011, 41 (03) :393-400
[145]   Carotid Intima Media Thickness in Rheumatoid Arthritis as Compared to Control Subjects: A Meta-Analysis [J].
van Sijl, Alper M. ;
Peters, Mike J. ;
Knol, Dirk K. ;
de Vet, Henrica C. ;
Gonzalez-Gay, Miguel A. ;
Smulders, Yvo M. ;
Dijkmans, Ben A. ;
Nurmohamed, Michael T. .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 2011, 40 (05) :389-397
[146]   Endothelial dysfunction in young patients with rheumatoid arthritis and low disease activity [J].
Vaudo, G ;
Marchesi, S ;
Gerli, R ;
Allegrucci, R ;
Giordano, A ;
Siepi, D ;
Pirro, M ;
Shoenfeld, Y ;
Schillaci, G ;
Mannarino, E .
ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 (01) :31-35
[147]   Use of Lipid-lowering Agents in Rheumatoid Arthritis: A Population-based Cohort Study [J].
Veetil, Bharath Manu Akkara ;
Myasoedova, Elena ;
Matteson, Eric L. ;
Gabriel, Sherine E. ;
Crowson, Cynthia S. .
JOURNAL OF RHEUMATOLOGY, 2013, 40 (07) :1082-1088
[148]  
Wiersma Tjerk, 2012, Ned Tijdschr Geneeskd, V156, pA5104
[149]   The inflammatory syndrome: The role of adipose tissue cytokines in metabolic disorders linked to obesity [J].
Wisse, BE .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2004, 15 (11) :2792-2800
[150]   Mortality in rheumatoid arthritis. Increased in the early course of disease, in ischaemic heart disease and in pulmonary fibrosis [J].
Young, A. ;
Koduri, G. ;
Batley, M. ;
Kulinskaya, E. ;
Gough, A. ;
Norton, S. ;
Dixey, J. .
RHEUMATOLOGY, 2007, 46 (02) :350-357
78910111213141516